All Stories

  1. Peptide Amphiphiles for Pharmaceutical Applications

    Article • Current Medicinal Chemistry, April 2024, Bentham Science Publishers

    Dr Isabel Haro

  2. Nanotechnology-Based Platforms for Vaginal Delivery of Peptide Microbicides

    Article • Current Medicinal Chemistry, August 2021, Bentham Science Publishers

    Dr Isabel Haro

  3. Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis

    Article • PLoS ONE, May 2019, PLOS

    Dr Isabel Haro

  4. Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), August 2017, De Gruyter

    Dr Isabel Haro

  5. A study of HIV-1 FP inhibition by GBV-C peptides using lipid nano-assemblies

    Article • Colloids and Surfaces A Physicochemical and Engineering Aspects, September 2015, Elsevier

    Dr Isabel Haro

  6. The Use of Citrullinated Peptides for the Diagnosis and Prognosis of Rheumatoid Arthritis

    Article • Current Topics in Medicinal Chemistry, January 2015, Bentham Science Publishers

    Dr Isabel Haro

  7. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery

    Article • International Journal of Nanomedicine, January 2015, Taylor & Francis

    Dr Isabel Haro, M LUISA GARCÍA

  8. A cyclic GB virus C derived peptide with anti-HIV-1 activity targets the fusion peptide of HIV-1

    Article • European Journal of Medicinal Chemistry, October 2014, Elsevier

    Dr Isabel Haro

  9. Updating the Use of Synthetic Peptides as Inhibitors of HIV-1 Entry

    Article • Current Medicinal Chemistry, March 2014, Bentham Science Publishers

    Dr Isabel Haro

  10. HIV-1 Inhibiting Capacity of Novel Forms of Presentation of GB Virus C Peptide Domains is Enhanced by Coordination to Gold Compounds

    Article • Current Medicinal Chemistry, December 2013, Bentham Science Publishers

    Dr Isabel Haro

  11. Editorial (Hot Topic:Rheumatoid Arthritis: Current Advances in Pathogenesis, Diagnosis and Therapy)

    Article • Current Topics in Medicinal Chemistry, April 2013, Bentham Science Publishers

    Dr Isabel Haro

  12. Citrullinated Peptides in the Diagnosis of Rheumatoid Arthritis

    Article • Current Topics in Medicinal Chemistry, April 2013, Bentham Science Publishers

    Dr Isabel Haro

  13. Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients

    Article • Arthritis Research & Therapy, January 2013, Springer Science + Business Media

    Dr Isabel Haro

  14. Design and application of GB virus C (GBV-C) peptide microarrays for diagnosis of GBV-C/HIV-1 co-infection

    Article • Analytical and Bioanalytical Chemistry, December 2012, Springer Science + Business Media

    Dr Isabel Haro

  15. Oligonucleotide-Peptide Conjugates: Solid-Phase Synthesis under Acidic Conditions and Use in ELISA Assays

    Article • Molecules, November 2012, MDPI AG

    Dr Isabel Haro, Ramon Eritja

  16. Physicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: Interaction with model membranes

    Article • International Journal of Pharmaceutics, October 2012, Elsevier

    Dr Isabel Haro

  17. Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease?

    Article • Clinical Rheumatology, March 2012, Springer Science + Business Media

    Dr Isabel Haro

  18. Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection

    Article • Journal of Peptide Science, March 2012, Wiley

    Dr Isabel Haro

  19. The Use of Chimeric Vimentin Citrullinated Peptides for the Diagnosis of Rheumatoid Arthritis

    Article • Journal of Medicinal Chemistry, November 2011, American Chemical Society (ACS)

    Dr Isabel Haro

  20. Biophysical Investigations of GBV-C E1 Peptides as Potential Inhibitors of HIV-1 Fusion Peptide

    Article • ChemPhysChem, September 2011, Wiley

    Dr Isabel Haro

  21. Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis

    Article • Biosensors and Bioelectronics, September 2011, Elsevier

    Dr Isabel Haro

  22. Effect of E1(64–81) hepatitis G peptide on the in vitro interaction of HIV-1 fusion peptide with membrane models

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, September 2011, Elsevier

    Dr Isabel Haro

  23. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C

    Article • Journal of Colloid and Interface Science, August 2011, Elsevier

    Dr Isabel Haro

  24. Diagnostic Value of Anti-GBV-C Antibodies in HIV-Infected Patients

    Article • Chemical Biology & Drug Design, June 2011, Wiley

    Dr Isabel Haro

  25. Antibodies against β-fibrin synthetic peptides: A study of their association with the immunogenetic background and disease course of rheumatoid arthritis patients

    Article • European Journal of Medicinal Chemistry, April 2011, Elsevier

    Dr Isabel Haro

  26. Synthesis of a New Series of Enkaphalin Related Galactosyl Conjugates

    Article • Bulletin des Sociétés Chimiques Belges, September 2010, Wiley

    Dr Isabel Haro

  27. Effect of Synthetic Peptides Belonging to E2 Envelope Protein of GB Virus C on Human Immunodeficiency Virus Type 1 Infection

    Article • Journal of Medicinal Chemistry, August 2010, American Chemical Society (ACS)

    Dr Isabel Haro

  28. A Langmuir Monolayer Study of the Interaction of E1(145−162) Hepatitis G Virus Peptide with Phospholipid Membranes

    Article • The Journal of Physical Chemistry, January 2010, American Chemical Society (ACS)

    Dr Isabel Haro

  29. Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection

    Article • Analytical Biochemistry, January 2010, Elsevier

    Dr Isabel Haro

  30. Synthetic Peptides of Hepatitis G Virus (GBV-C/HGV) in the Selection of Putative Peptide Inhibitors of the HIV-1 Fusion Peptide

    Article • The Journal of Physical Chemistry, May 2009, American Chemical Society (ACS)

    Dr Isabel Haro

  31. Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: Its interaction with phospholipid membrane models

    Article • Biophysical Chemistry, May 2009, Elsevier

    Dr Isabel Haro

  32. Fluorescence study of the dynamic interaction between E1(145–162) sequence of hepatitis GB virus C and liposomes

    Article • Analytical and Bioanalytical Chemistry, January 2009, Springer Science + Business Media

    Dr Isabel Haro

  33. Synthesis and biological activity of substance P analogues

    Article • International journal of peptide & protein research, January 2009, Wiley

    Dr Isabel Haro

  34. Interaction of GB Virus C/Hepatitis G Virus Synthetic Peptides with Lipid Langmuir Monolayers and Large Unilamellar Vesicles

    Article • The Journal of Physical Chemistry, January 2009, American Chemical Society (ACS)

    Dr Isabel Haro

  35. Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis

    Article • Arthritis Research & Therapy, January 2009, Springer Science + Business Media

    Dr Isabel Haro

  36. Peptide-Based Diagnostic Assays

    Article • December 2008, Taylor & Francis

    Dr Isabel Haro

  37. Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage

    Article • Biophysical Chemistry, January 2008, Elsevier

    Dr Isabel Haro

  38. Antibodies to Citrullinated Human Fibrinogen Synthetic Peptides in Diagnosing Rheumatoid Arthritis

    Article • Journal of Medicinal Chemistry, July 2007, American Chemical Society (ACS)

    Dr Isabel Haro

  39. Synthesis of Overlapping Fibrin Citrullinated Peptides and their use for Diagnosing Rheumatoid Arthritis

    Article • Chemical Biology & Drug Design, October 2006, Wiley

    Dr Isabel Haro

  40. Interfacial Properties of a Synthetic Peptide Derived from Hepatitis G Virus E2 Protein:  Interaction with Lipid Monolayers

    Article • Langmuir, January 2006, American Chemical Society (ACS)

    Dr Isabel Haro

  41. Characterization of a putative fusogenic sequence in the E2 hepatitis G virus protein

    Article • Archives of Biochemistry and Biophysics, October 2005, Elsevier

    Dr Isabel Haro

  42. Interaction of synthetic peptides corresponding to hepatitis G virus (HGV/GBV-C) E2 structural protein with phospholipid vesicles

    Article • FEBS Journal, April 2005, Wiley

    Dr Isabel Haro

  43. Perturbations induced by synthetic peptides from hepatitis G virus structural proteins in lipid model membranes: a fluorescent approach

    Article • Luminescence, January 2005, Wiley

    Dr Isabel Haro

  44. Analysis of the effect of a peptide sequence of the E2 protein (HGV/GBV-C) on the physicochemical properties of zwitterionic and negatively charged bilayers

    Article • Luminescence, January 2005, Wiley

    Dr Isabel Haro

  45. Design of Synthetic Peptidic Constructs for the Vaccine Development Against Viral Infections

    Article • Current Protein and Peptide Science, December 2004, Bentham Science Publishers

    Dr Isabel Haro

  46. Effects of Overlapping GB Virus C/Hepatitis G Virus Synthetic Peptides on Biomembrane Models

    Article • Langmuir, December 2004, American Chemical Society (ACS)

    Dr Isabel Haro

  47. Interaction of three β-interferon domains with liposomes and monolayers as model membranes

    Article • Biophysical Chemistry, October 2004, Elsevier

    Dr Isabel Haro

  48. Study in mono and bilayers of the interaction of hepatitis G virus (GBV-C/HGV) synthetic antigen E2(99-118) with cell membrane phospholipids

    Article • Biophysical Chemistry, June 2004, Elsevier

    Dr Isabel Haro

  49. Interaction of Antimicrobial Arginine-Based Cationic Surfactants with Liposomes and Lipid Monolayers

    Article • Langmuir, April 2004, American Chemical Society (ACS)

    Dr Isabel Haro

  50. Peptides and Liposomes: From Biophysical to Immunogenic Studies

    Article • Current Drug Targets, November 2003, Bentham Science Publishers

    Dr Isabel Haro

  51. GB Virus C (GBV-C) / Hepatitis G Virus (HGV): Towards the Design of Synthetic Peptides-based Biosensors for Immunodiagnosis of GBV-C / HGV Infection

    Article • Current Protein and Peptide Science, August 2003, Bentham Science Publishers

    Dr Isabel Haro

  52. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design

    Article • FEBS Letters, March 2003, Wiley

    Dr Isabel Haro

  53. Miscibility of Hepatitis A Synthetic Antigen Peptides with Lipid Monolayers:  Effect of the Amino Acid Sequence Change

    Article • The Journal of Physical Chemistry, January 2003, American Chemical Society (ACS)

    Dr Isabel Haro

  54. Synthesis and surface activity measurements of HGV NS3 (513–522) peptide and its palmitoyl derivative

    Article • Materials Science and Engineering C, December 2002, Elsevier

    Dr Isabel Haro

  55. Use of [Cit312,314] filaggrin (306–324) analogue for the diagnosis of rheumatoid arthritis. Conformational study by circular dichroism and fourier transformed infrared spectroscopy

    Article • November 2002, Springer Science + Business Media

    Dr Isabel Haro

  56. Interfacial Interactions of Hydrophobic Peptides with Lipid Bilayers

    Article • Journal of Colloid and Interface Science, February 2002, Elsevier

    Dr Isabel Haro

  57. Hydrophobic Laminin-Related Peptides: Synthesis and Surface Properties

    Article • Journal of Colloid and Interface Science, July 2001, Elsevier

    Dr Isabel Haro

  58. Phospholipid−Model Membrane Interactions with Branched Polypeptide Conjugates of a Hepatitis a Virus Peptide Epitope

    Article • Bioconjugate Chemistry, January 2000, American Chemical Society (ACS)

    Dr Isabel Haro

  59. Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus

    Article • FEBS Letters, October 1998, Wiley

    Dr Isabel Haro

  60. Conformational behavior of the HAV-VP3(110–121) peptidic sequence and synthetic analogs in membrane environments studied by CD and computational methods

    Article • Biopolymers, June 1998, Wiley

    Dr Isabel Haro

  61. Conformational behavior of the HAV‐VP3(110–121) peptidic sequence and synthetic analogs in membrane environments studied by CD and computational methods

    Article • Biopolymers, June 1998, Wiley

    Dr Isabel Haro

  62. A new continuous epitope of hepatitis A virus

    Article • Journal of Medical Virology, February 1998, Wiley

    Dr Isabel Haro

  63. Physicochemical study of laminin-related peptides

    Article • Supramolecular Science, September 1997, Elsevier

    Dr Isabel Haro

  64. Interactions of a tetravalent branched peptide from VP3 capsid protein of hepatitis A virus with monolayers as biomembrane models

    Article • Supramolecular Science, September 1997, Elsevier

    Dr Isabel Haro

  65. Conformational study of the preferred conformations of the peptide sequence VP3(110–121) of HAV by circular dichroism and molecular mechanics

    Article • March 1997, Springer Science + Business Media

    Dr Isabel Haro

  66. Anti-Hepatitis A Virus Antibody Response Elicited in Mice by Different Forms of a Synthetic VP1 Peptide

    Article • Microbiology and Immunology, July 1995, Wiley

    Dr Isabel Haro

  67. Physicochemical study of hepatitis A and B peptide fragments with monolayers as membrane models

    Article • Journal of Colloid and Interface Science, August 1992, Elsevier

    Dr Isabel Haro

  68. Solid phase synthesis of potential antigenic peptides and new lipopeptides of hepatitis B virus

    Article • Journal of the Chemical Society Perkin Transactions 1, January 1991, Royal Society of Chemistry

    Dr Isabel Haro

  69. A Synthetic Glycopeptide of Substance P Analogue (SP6–11) with Enhanced NK-1 Receptor Specificity

    Article • Journal of Pharmaceutical Sciences, January 1990, Elsevier

    Dr Isabel Haro

  70. In vitro activity and selectivity of glucosidic SP(66-11) analogues

    Article • Pharmacology Biochemistry and Behavior, November 1989, Elsevier

    Dr Isabel Haro

  71. Hydrophobic peptides: Synthesis and interaction with model membranes

    Article • Springer Science + Business Media

    Dr Isabel Haro